The increasing complexity of malignant diseases treatment necessitates a comprehensive understanding of diverse healthcare approaches. This article aims to investigate the strengths and limitations of transatlantic cancer care, comparing the practices in both the United States and Europe. Through a systemic lens, we will assess key variables, inclu